Background Patients presenting with acute myeloid leukemia (AML) at diagnosis are at high
risk of severe complications and death, particularly with high white blood cell (WBC) count …

Hematological malignancies may require rapid-onset treatment because of their short
doubling time, notably observed in acute leukemias and specific high-grade lymphomas …

Purpose Acute promyelocytic leukaemia (APL) therapy with all-trans retinoic acid and
chemotherapy is associated with a high cure rate in clinical trials. As some patients are not …

Introduction Patients with hematological malignancies (HM) require intensive chemotherapy
with curative intent, especially in case of AML that results in more frequent admissions to …

Introduction Patients with hyperleukocytic (HL) acute myeloid leukemia (AML) are at higher
risk of early death. Initial management of these patients is challenging, not fully codified and …

No data are available on outcomes of patients with lymphoma requiring intensive care unit
(ICU) admission. We retrospectively studied 190 patients admitted to our ICU between 2000 …

An increasing number of critically ill patients is immunocompromised [1, 2], and half of them
are treated for hematological malignancies [3]. In hematology patients, admission in an …

Purpose Patients with hematological malignancies are at high risk for life-threatening
complications. To date, little attention has been paid to the impact of hyperoxemia and …

Background Older adults with acute myeloid leukemia (AML) are often assumed to have
poor outcomes after admission to the intensive care unit (ICU). However, little is known …

Cancer survival has been steadily improving over the last few decades owing to earlier
detection, advances in surgical and medical options for treatment, and better supportive …